msC htospitfllLty Presents:
Halloween Party!
Fft.cw.lty, stft-pf, fttA/fti stwftleiA,ts' chiLdreyi art U^vlttd
tc weftr their favorite costwrwe ftrvftl ewjoy ft
spoote-tftcwlftr w,l0ht of free 0ftrM.es, prizes,
refreshments ftrvd ft hftwntefti twnnel!
4%.
October 23, 2003
6-8 PM, 2 nd floor of the MSC (rm. 201)
• Pmotlms of pptft used baotes will be Accepted at tbe
doer to beiA-eflt the msc Hospitality B>oofe Drive. •
Relax, Rejuvenate and Unwind. Let the professionals at
Riviera Day Spa
take care of all your spa needs!
Specials
Microdermabrasion $ 99
Riviera Facial s 50
I Hour Massage $ 50
Specials good through Nov. 15, 2003.
Not good on gift certificates or packages.
Call Riviera Day Spa for an appointment.
695-0327 • 1800 Brothers Blvd., College Station
Buy 2 Dozen Original
Glazed Doughnuts for $8.99
Offer valid thru 1/1/04 at
any College Station or
Bryan Kroger location.
NATION
THE BATTALION
6A ATION
Thursday, October 23,2003 ifHE BATTALK
California wildfires burn six homes
By Paul Chavez
THE ASSOCIATED PRESS
LOS ANGELES — High
temperatures helped spur four
wildfires in Southern California,
including a fast-moving arson
blaze that destroyed six homes
in the Reche Canyon area of
Riverside County, officials said.
The hot weather also stoked
fires in Fontana, Camp
Pendleton and the hills above
Burbank.
The blaze in Reche Canyon
was reported Tuesday afternoon
and by early Wednesday had
burned at least 1,000 acres, said
Becky Luther, a spokeswoman
for the California Department of
Forestry. Investigators deter
mined that it was set, he said.
It destroyed six homes and
on Wednesday it was threaten
ing about 100 homes, said CDF
Capt. Rick Vogt. The blaze was
10 percent contained, he said.
Mark Josephson and his
friends and family members
fought alongside firefighters as
the blaze threatened his Reche
Canyon home. He had 12 hors
es, a goat and several sheep on
his property, and the neighing of
frightened horses could be heard
above the din of helicopters.
“Flames came within a foot
of the house,” Josephson said.
“We didn’t lose anything.”
Evacuations were ordered
and about a dozen residents
spent the night in a nearby
school, Vogt said. More than
530 firefighters were battling
the blaze and one firefighter suf
fered from smoke inhalation.
There were no other injuries,
Vogt said.
Southern California has
experienced record, triple-digit
temperatures in recent days and
the warm weather is expected to
continue for the next few days.
A high of 95 was forecast
Wednesday in Riverside.
Another wildfire charred
2,000 acres at the far north end
of Fontana in San Bernardino
County. The blaze, which was
burning away from homes, was
under investigation, said Bill
Peters, a CDF spokesman.
In the hills above Burbank, a
suspicious wildfire covered
about KM) acres, said Dave Starr,
spokesman for the Burbank Fire
Department. Crews expected to
have the blaze contained
Wednesday.
A brush fire at Camp
Pendleton blackened more than
1,000 acres in an uninhabited
area used for training exercises
at the Marine base. Authorities
said the blaze was apparently
started by ammunition.
Blazes flare up in
Southern California
Wildfires broke out in the Reche
Canyon area, Fontana, Camp
Pendleton and in the hills above
Burbank. At least six homes were
destroyed.
5} CALIFORNIA ^
Burbank
v. Fontana
—vj?/ 4^'
Los i Reche
Angeles
4c<
Wildfires
anyon
Camp' ®
Pendleton
Yv Pacific Ocean — „
vjfps/m
0 25 mi San
0 25 km
I
SOURCE : Associated Press AP
D'ego^
Student whose father died in windshield gets
$10,000 scholarship from death-row opponents
By Angela K. Brown
THE ASSOCIATED PRESS
DALLAS — Death-row
opponents on Wednesday gave
a $10,000 scholarship to a
college student whose father
was hit by a car and left to die
in the windshield.
The money for Brandon
Biggs was raised through
donations and subscriptions to
“Compassion,” a bimonthly
newsletter written by the
nation’s death-row inmates
and a project of the Roman
Catholic church’s peace and
justice committee.
“We want to debunk the
myth that death-row inmates
are subhuman monsters need
ing to be killed,” Rick
Halperin, the Texas death
penalty abolition coordinator
for Amnesty International
USA, said after the scholarship
presentation at a Dallas church.
Gregory Biggs was walking
on the side of a Fort Worth
highway in October 2001 when
he was hit.
With his torso in the car and
his broken legs lodged in the
windshield, he held onto the
inside passenger door panel and
may have begged for help as
the car kept going, according to
court testimony. He died a few
hours after the driver parked in
her garage and left the house.
Chante Mallard was convict
ed in June of murder and
sentenced to 50 years in prison.
She was not eligible for the
death penalty; her maximum
punishment would have been
life in prison.
The scholarship money is
for relatives of any murder
victims, not just those in death-
penalty cases.
During her trial, Mallard tes
tified that her judgment was
clouded by drugs and alcohol
after a night at a bar, and that
she was afraid of being arrest
ed. She also apologized to
Brandon Biggs, sobbing.
Brandon Biggs later said he
forgave Mallard.
“I still want to extend my
forgiveness to Chante Mallard
and I want the Mallard family
to know that they are in my
prayers,” he said Wednesday.
Brandon Biggs said he
respects prisoners who are try
ing to give back to society. He
would not say whether he
opposes the death penalty but
said overturning a death
sentence would be a “great act
of mercy.”
Fred Moor, the
“Compassion” coordinator and
a member of St. Rose Parish in
Perrysburg, Ohio, said he heard
about the case and contacted
Brandon Biggs about applying
for a scholarship.
Few murder victims’ rela
tives want to accept money
from death-row inmates. Moor
sard. Brandon Biggs is only the
third scholarship recipient.
“A family member has been
murdered, so for them to go to
a prisoner and ask for some
thing is very difficult to do,”
Moor said.
No scholarship applicants
are asked about their feelings on
the death penalty. Moor said.
The Catholic Diocese of
Toledo, Ohio, handles ihe
Finances of the scholarship
fund and newsletter, which is
sent to the nation’s 3,500
death-row inmates. Prisoners
do not get paid for working on
the publication.
“Brandon Biggs is an
excellent example of compas
sion,” Missouri death row
inmate Dennis Skillicorn wrote
in the newsletter’s September
issue. “Brandon’s response (to
Mallard) was far from typical.”
Brandon Biggs, 20, is a
sophomore pastoral ministry
student at Southwestern
Assembly of God University in
Waxahachie, about 25 miles
southwest of Dallas.
He said his father, a brick
layer, lost his car and home
after loaning money to a friend
about two years earlier.
Brandon Biggs said he visited
his father at a Fort Worth home
less shelter several times before
his death.
NEWS IN BRIEF
Football "pray-in" causes
controversy in Loranger
LORANGER, La. (AP) — A “pray in”
before the latest Loranger High School
football game drew enough people to sur
round the football field in what amounted
to a protest against the American Civil
Liberties Union.
LHS is a target in the third ACLU-related
lawsuit over religion filed against the
school board in the last nine years.
The latest complaint was filed in federal
court Tuesday in New Orleans on behalf of
a Loranger resident identified only as
John Doe and minor sons James and Jack
Doe, who are LHS students.
The complaint alleges the school board
endorses prayers or religion at LHS foot
ball games, during the school day and at
board meetings, in violation of school pol
icy and the Constitution.
Loranger United Methodist Church sold
shirts Friday saying, “Yes, I’ll pray,”
School Board member Sandra Bailey-
Simmons said.
Louisiana ACLU director Joe Cook said
he watched the “pray-in” on television.
“The message that was sent that night
was ‘only Christians are welcome here at
this event,”’ Cook said. “It also sends a
very bad message to students that the
majority can trump the rights of those in
the minority or those who believe in the
separation of church and state.”
By Adam i
THE ASSOCIAT
NEW YORK
iployers who
■ecommuting, jol
impressed work
impetitive job it
190s are cutting
rork/life” progrr
The programs,
ve workers moi
eseen as easy ite
ally strained b
iminate, anal
Ihough some ad
ipular programs
inies and employ
“It’s hard econ
id Lori Rosen,
lalyst for CC
iverwoods, lll.-b;
formation pub
leased a survey
ograms Wednesi
e saying where c
'slocking like th
ell this is a benef
intake it away.”
The survey of n
nployers found
es offering
opped from 37
X)2 to 30 perce
lenate
ontinued from
nendment to I in
le line-item budge
) students and pa
Her failed.
Chair John Mat
iriieved the
liould be more r
We to students.
“It’s students’ n
iey want to know '
teyhave the right ti
natter of principle,’
Earlier in the ev<
hairs of the Senate
'Democratic
tadment” to
iConstition as erne
ta, a bill that the;
nan unusual show
ikins said.
“The solidarity <
fficers on this issu
tangly we believe
ovemment,” he sai
The amendment
o strengthen the
etween the Sen,
ixecutive Branch ai
igislation the Sen
ddressed by the ;
ixecutive Council
latasha Eubanks.
“We are calling
iip,” she said. “(1
Iso for our voice tc
■ ^ .i.g 4 ^ U
Contraceptive Injection
medroxyprogesterone acetate injectable suspension
DEPO-PROVERA” Contraceptive Injection
(medroxyprogesterone acetate injectable suspension, USP)
This product is intended to prevent pregnancy. It does not protect against HIV
infection (AIDS) and other sexually transmitted diseases.
What is DEPO-PROVERA Contraceptive Injection?
DEPO-PROVERA Contraceptive Injection is a form of birth control-that is given as an
intramuscular injection (a shot) in the buttock or upper arm once every 3 months (I 3 weeks). To
continue your contraceptive protection, you must return for your next injection promptly at the
end of 3 months (13 weeks). DEPO-PROVERA contains medroxyprogesterone acetate, a
chemical similar to (but not the same as) the natural hormone progesterone, which is produced
by your ovaries during the second half of your menstrual cycle. DEPO-PROVERA acts by
preventing your egg cells from ripening. If an egg is not released from the ovaries during your
menstrual cycle, it cannot become fertilized by sperm and result in pregnancy. - DEPO-PROVERA
also causes changes in the lining of your uterus that make it less likely tor pregnancy to occur.
How effective is DEPO-PFiOVERA Contraceptive Injection?
The efficacy of DEPO-PROVERA Contraceptive Injection depends on following the
recommended dosage schedule exactly (see "How often do I get my shot of DEPO-PROVERA
Contraceptive Injection?"). To make sure you are not pregnant when you first get
DEPO-PROVERA Contraceptive Injection, your first injection must be given ONLY during
the first 5 days of a normal menstrual period; ONLY within the first 5 days after childbirth if not
breast-feeding; and, jf exclusively breast-feeding, ONLY at the sixth week after childbirth. It is a
long-term injectable contraceptive when administered at 3-month (13-week) intervals.
DEPO-PROVERA Contraceptive Injection is over 99% effective, making it one of the most reliable
methods of birth control available. This means that the average annual pregnancy rate is less than
one for every 100 women who use DEPO-PROVERA. The effectiveness of most contraceptive
methods depends in part on how reliably each woman uses the method. The effectiveness of
DEPO-PROVERA depends only on the patient returning every 3 months (13 weeks) for her next
injection. Your health-care provider will help you compare DEPO-PROVERA with other
contraceptive methods and give you the information you need in order to decide which
contraceptive method is the right choice for you.
The following table shows the percent of women who got pregnant while using different kinds of
contraceptive methods. It gives both the lowest expected rate of pregnancy (the rate expected
in women who use each method exactly as it should be used) and the typical rate of pregnancy
(which includes women who became pregnant because they forgot to use their birth control or
because they did not follow the directions exactly).
Percent of Women Experiencing an Accidental Pregnancy
in the First Year of Continuous Use
Method
Lowest
Expected
Typical
DEPO-PROVERA
0.3
0.3
Implants (Norplant)
0.2*
0.2*
Female sterilization
0.2
0.4
Male sterilization
0.1
0.15
Oral contraceptive (pill)
3
Combined
0.1
Progestogen only
0.5
IUD
3
Progestasert
2.0
Copper! 380A
0.8
Condom (without spermicide)
2
12
Diaphragm (with spermicide)
6
18
Cervical cap
6
18
Withdrawal
4
18
Periodic abstinence
1-9
20
Spermicide alone
3
21
Vaginal Sponge
used before childbirth
6
18
used after childbirth
9
28
No method
85
85
Source: Trussed et al. Obstet Gynecol. 1990:76:558-567.
•From Norplant" package insert.
Who should not use DEPO-PROVERA Contraceptive Injection?
Not all women should use DEPO-PROVERA. You should not use DEPO-PROVERA if you have
any of the following conditions:
• if you think you might be pregnant
• if you have any vaginal bleeding without a known reason
B>irtK oon-trol you-tKirvk aB-out jus-t ‘+xayear
• if you have had cancer of the breast
• if you have had a stroke
• if you have or have had blood clots (phlebitis) in your legs
• if you have problems with your liver or liver disease
• if you are allergic to DEPO-PROVERA (medroxyprogesterone acetate or any of its other
ingredients).
What other things should I consider before using DEPO-PROVERA
Contraceptive Injection?
You will have a physical examination before your doctor prescribes DEPO-PROVERA. It is
important to tell your health-care provider if you have any of the following:
• a family history of breast cancer
• an abnormal mammogram (breast x-ray), fibrocystic breast disease, breast nodules or lumps, or
bleeding from your nipples
• kidney disease
• irregular or scanty menstrual periods
• high blood pressure
• migraine headaches
• asthma
• epilepsy (convulsions or seizures)
• diabetes or a family history of diabetes
• a history of depression
• if you are taking any prescription or over-the-counter medications
This product is intended to prevent pregnancy. It does not protect against
transmission of HIV (AIDS) and other sexually transmitted diseases such as
chlamydia, genital herpes, genital warts, gonorrhea, hepatitis B, and syphilis.
What if I want to become pregnant after using DEPO-PROVERA Contraceptive
Injection?
Because DEPO-PROVERA is a long-acting birth control method, itrtakes some time after your last
injection for its effect to wear off. Based on the results from a large study done in the United States,
for women who stop using DEPO-PROVERA in order to become pregnant, it is expected that
about half of those who become pregnant will do so in about 10 months after their last injection;
about two thirds of those who become pregnant will do so in about 12 months; about 83% of
those who become pregnant will do so in about 15 months; and about 93% of those who become
pregnant will do so in about 18 months after their last injection. The length of time you use
DEPO-PROVERA has no effect on how longit takes you to become pregnant after you stop using it
What are the risks of using DEPO-PROVERA Contraceptive Injection?
/ .Irregular Menstrual Bleeding
The side effect reported most frequently by women who use DEPO-PROVERA for
contraception is a change in their normal menstrual cycle. During the first year of using
DEPO-PROVERA, you might have one or more of the following changes: irregular or
unpredictable bleeding or spotting, an increase or decrease in menstrual bleeding, or no Bleeding
at all. Unusually heavy or continuous bleeding, however is not a usual effect of DEPO-PROVERA;
and if this happens, you should see your health-care provider right away. With continued use of
DEPO-PROvERA, bleeding usually decreases, and many women stop having periods completely.
In clinical studies of DEPO-PROVERA, 55% of the women studied reported no menstrual
bleeding (amenorrhea) after I year of use, and 68% of the women studied reported no menstrual
bleeding after 2 years of use. The reason that your periods stop is because DEPO-PROVERA
causes a resting state in your ovaries. When your ovaries do not release an egg monthly, the
regular monthly growth of the lining of your uterus does not occur and, therefore, the bleeding
that comes witn your normal menstruation does not take place. When you stop using
DEPO-PROVERA your menstrual period will usually, in time, return to its normal cycle.
2. Bone Mineral Changes
. Use of DEPO-PROVERA may be associated with a decrease in the amount of mineral stored in
your bones. This could increase your risk of developing bone fractures. The rate of bone mineral
loss is greatest in the early years of DEPO-PROVERA use, but after that, it begins to resemble the
normal rate of age-related bone mineral loss.
3. Cancer
Studies of women who have used different forms of contraception found that women who used
DEPO-PROVERA for contraception had no increased overall risk of developing cancer of the
breast, ovary, uterus, cervix, or liver However women under 35 years of age whose first exposure
to DEPO-PROVERA was within the previous 4 to 5 years may have a slightly increased risk of
developing breast cancer similar to that seen with oral contraceptives. You should discuss this with
your health-c
i-care provider
4. Unexpected Pregnancy
Because DEPO-PROVERA is such an effective contraceptive method, the risk of accidental
pregnancy for women who get their shots regularly (every 3 months [ 13 weeks]) is very low.
While there have been reports of an increased risk of low birth weight and neonatal infant death
or other health problems in infants conceived close to the time of injection, such pregnancies are
uncommon. If you think you may have become pregnant while using DEPO-PROVERA for Rx only
contraception, see your health-care provider as soon as possible.
5. AIIergic Reactions
Some women using DEPO-PROVERA Contraceptive Injection have reported severe and
potentially life-threatening allergic reactions known as anaphylaxis and anaphylactoid reactions.
Symptoms include the sudden onset of hives or swelling and itching of the skin, breathing
difficulties, and a drop in blood pressure.
6. Other Risks
Women who use hormone-based contraceptives may have an increased risk of blood clots or
stroke. Also, if a contraceptive method fails, there is a possibility that the fertilized egg will begin
to develop outside of the uterus (ectopic pregnancy). While these events are rare, you should
tell your health-cane provider if you have any of the problems listed in the next section.
What symptoms mav signal problems while using DEPO-PROVERA
Contraceptive Injection?
Call your health-care provider immediately if any of these problems occur following an injection
of DEPO-PROVERA:
• sharp chest pain, coughing up of blood, or sudden shortness of breath (indicating a possible clot
in the lung)
• sudden severe headache or vomiting, dizziness or fainting, problems with your eyesight or
speech, weakness, or numbness in an arm or leg (indicating a possible stroke)
• severe pain or swelling in the calf (indicating a possible clot in the leg)
• unusually heavy vaginal bleeding
• severe pain or tenderness in the lower abdominal area
• persistent pain, pus, or bleeding at the injection site
What are the possible side effects of DEPO-PROVERA Contraceptive Injection?
/.Weight Gain
You may experience a weight gain while you are using DEPO-PROVERA. About two thirds of
the women who used DEPO-PROVERA in clinical trials reported a weight gain of about 5 pounds
during the first year of use. You mav continue to gain weight after the first year Women in one
large study who used DEPO-PROVERA for 2 years gained an average total of 8.1 pounds over
those 2 years, or approximately 4 pounds per year Women who continued for 4 years gained an
average total of 13.8 pounds over those 4 years, or approximately 3.5 pounds per year Women
who continued for 6 years gained an average total of 16.5 pounds over those 6 years, or
approximately 2.75 pounds per year
2.Other Side Effects
In a clinical study of over 3,900 women who used DEPO-PROVERA for up to 7 years, some
women reported the following effects that may or may not have been related to their use of
DEPO-PROVERA: Irregular menstrual bleeding, amenorrhea, headache, nervousness, abdominal
cramps, dizziness, weakness or fatigue, decreased sexual desire, leg cramps, nausea, vaginal
discharge or irritation, breast swelling and tenderness, bloating, swelling of the hands or feet,
backache, depression, insomnia, acne, pelvic pain, no hair growth or excessive hair loss, rash, hot
flashes, and joint pain. Other problems were reported by very few of the women in the clinical
trials, but some of these could be serious. These include convulsions, jaundice, urinary tract
infections, allergic reactions, fainting, paralysis, osteoporosis, lack of return to fertility, deep vein
thrombosis, pufmonary embolus, breast cancer or cervical cancer If these or any other problems
occur during your use of DEPO-PROVERA, discuss them with your health-care provider
Should any precautions be followed during use of DEPO-PROVERA
Contraceptive Injection?
/ .Missed Periods
During the time you are using DEPO-PROVERA for contraception, you mav skip a period, or your
periods may stop completely. If you have been receiving your DEPO-PROVERA injections
regularly every 3 months (13 weeks), then you are probably not pregnant. However if you think
that you may be pregnant, see your health-care provider
2. Laboratory Test Interactions
If you are scheduled for any laboratory tests, tell your health-care provider that you are using
DEPO-PROVERA'for contraception. Certain blood tests are affected by hormones such as
DEPO-PROVERA.
3. Drug Interactions
Cytadren (aminoglutethimide) is an anticancer drug that may significantly decrease the
effectiveness of DEPO-PROVERA if the two drugs are given during the same time.
4. Nursing Mothers
Although DEPO-PROVERA can be passed to the nursing infant in the breast milk, no harmful
effects nave been found in these children. DEPO-PROVERA does not prevent the breasts from
producing milk, so it can be used by nursing mothers. However, to minimize the amount of
DEPO-PROVERA that is passed to tne infant in the first weeks after birth, you should wait until
6 weeks after childbirth before you start using DEPO-PROVERA for contraception.
How often do I get my shot of DEPO-PROVERA Contraceptive Injection?
The recommended dose of DEPO-PROVERA is 150 mg every 3 months (13 weeks) given in a
single intramuscular injection in the buttock or upper arm. To make sure that you are not pregnant
at the time of the first injection, it is essential that the injection be given ONLY during the first
5 days of a normal menstrual period. If used following the delivery of a child, the first injection of
DEPO-PROVERA MUST be given within 5 days after childbirth if you are not breast-feeding or
6 weeks after childbirth if you are exclusively breast-feeding. If you wait longer than 3 months
(13 weeks) between injections, or longer than 6 weeks after delivery, your health-care provider
should determine that you are not pregnant before giving you your injection of DEPO-PROVERA.
Pharmacia & Upjohn Company
Kalamazoo, Ml 49001, USA
CB-7-S
prS Pharmacia
& Upjohn
'/’<£« TVoiIcCa Aanqiat
theclogstore.com
1 - 800-948-CLOG
KAPP
WHEN:
October 24 ft 25,,
from 8 pm -1 am
WHERE:
Kappa Sigma Hou
4466 Raymond St
College Station, T<
J/2 JfL. Come One! Come All! Come emu!
- Starting Times-
Tues Wed-Thur-Sat Friday Sunday
6:45 6:45 & 9:00 7:15 & 9:00 6:00 & 8:00
EXPERIENCE THE
THRILL OF WINNING yjjflf
Large Non-Smoking RooiT^
• Dwr Pww ■ Gm Rxid-Scam'Pm Tabs mMva Matt!
Due lo recent elmges, no one under 18 is allowed In enter
Over $30,000 Won Each Week
St. Joseph St. Josh FREE
Cathouc School CamucChkh SPACE
IN THE AFTERNOON!
Radio News
from the newsroom of
THE BATTALION
campus and community news
1:57 p.m.
Monday through Friday
on KAMU-FM 90.9
College Station / Bryan
$10 OR $7 & One I
FOR MORE INFO:
Contact Kappa Si(
*1979-288-1159
Plar
In A«
“Bryan’s most cc
ness...”
“The clinic has
than 1,800 surg
- Bryan-Coll
“The clinic in E
tinguished amo
owned by Plan
for having argui
tive and consi
presence.”
- Bryan-Colle